Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity
- PMID: 24330069
- DOI: 10.1111/ceo.12280
Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity
Abstract
Background: To describe outcomes in a cohort of extremely premature infants treated for aggressive posterior retinopathy of prematurity by diode laser panretinal photocoagulation.
Design: Retrospective study.
Participants: Fifteen eyes in eight infants.
Methods: A review was carried out on infants between 23 and 25.6 weeks gestational age admitted to The Royal Brisbane and Women's Hospital neonatal intensive care unit between 1992 and 2009.
Main outcome measures: Success of treatment, visual and refractive outcomes.
Results: Five hundred fifty-four infants were admitted to neonatal intensive care unit, 373 survived till screening, and 304 had retinopathy of prematurity. Sixty-six infants required treatment, and eight of these had aggressive posterior retinopathy of prematurity (2.5% of all infants with retinopathy of prematurity). Mean gestational age was 24.2 weeks, mean birthweight was 634 g, and treatment occurred at mean 34.1 weeks post-menstrual age. The mean total number of burns per eye was 2967. Five of 15 treated eyes required retreatment. Two patients subsequently died of unrelated causes. Regression occurred in 9 of 11 remaining eyes; one eye progressed to stage 4b and another to stage 5 retinopathy of prematurity. Vitrectomy was performed in two eyes. Five eyes had 6/12 vision, one had 3/60, and three had no perception of light. Of the remaining two eyes, one had good fixation and the other had poor fixation.
Conclusions: Despite good structural outcomes, visual outcomes for conventional laser treatment of aggressive posterior retinopathy of prematurity are poor.
Keywords: ROP; laser; prematurity.
© 2013 Royal Australian and New Zealand College of Ophthalmologists.
Similar articles
-
Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period.Clin Exp Ophthalmol. 2013 Mar;41(2):159-66. doi: 10.1111/j.1442-9071.2012.02839.x. Clin Exp Ophthalmol. 2013. PMID: 22712637
-
Aggressive posterior retinopathy of prematurity.Retina. 2010 Apr;30(4 Suppl):S37-40. doi: 10.1097/IAE.0b013e3181cb6151. Retina. 2010. PMID: 20224476
-
Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period.Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):93-9. doi: 10.1111/j.1442-9071.2011.02724.x. Epub 2011 Dec 23. Clin Exp Ophthalmol. 2012. PMID: 22044448
-
Long term functional and structural outcomes of laser therapy for retinopathy of prematurity.Br J Ophthalmol. 2006 Jun;90(6):754-9. doi: 10.1136/bjo.2005.068304. Br J Ophthalmol. 2006. PMID: 16714267 Free PMC article. Review.
-
Literature review informs clinical guidelines for pain management during screening and laser photocoagulation for retinopathy of prematurity.Acta Paediatr. 2019 Apr;108(4):593-599. doi: 10.1111/apa.14523. Epub 2018 Aug 29. Acta Paediatr. 2019. PMID: 30054933 Review.
Cited by
-
Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity.J Curr Ophthalmol. 2017 Aug 24;30(1):80-84. doi: 10.1016/j.joco.2017.08.007. eCollection 2018 Mar. J Curr Ophthalmol. 2017. PMID: 29564414 Free PMC article.
-
Bevacizumab or laser for aggressive posterior retinopathy of prematurity.Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):243-248. doi: 10.4103/tjo.tjo_69_18. Taiwan J Ophthalmol. 2018. PMID: 30637196 Free PMC article.
-
Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment.J Ophthalmic Vis Res. 2021 Jul 29;16(3):400-407. doi: 10.18502/jovr.v16i3.9437. eCollection 2021 Jul-Sep. J Ophthalmic Vis Res. 2021. PMID: 34394869 Free PMC article.
-
A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.PLoS One. 2015 Jun 17;10(6):e0129383. doi: 10.1371/journal.pone.0129383. eCollection 2015. PLoS One. 2015. PMID: 26083024 Free PMC article.
-
Refractive outcomes following yttrium aluminum garnet laser (532 nm green laser) in severe retinopathy of prematurity.Oman J Ophthalmol. 2022 Nov 2;15(3):331-336. doi: 10.4103/ojo.ojo_315_21. eCollection 2022 Sep-Dec. Oman J Ophthalmol. 2022. PMID: 36760960 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources